APA (7th ed.) Citation

J, W., J, S., CH, S., E, H., JS, T., M, N., . . . TH, M. (2026). Risk-guided disease management to prevent heart failure in adult cancer survivors of previous cardiotoxic cancer treatments: Baseline results of the REDEEM trial. American heart journal, 292, 107277. https://doi.org/10.1016/j.ahj.2025.09.009

Chicago Style (17th ed.) Citation

J, Wong, et al. "Risk-guided Disease Management to Prevent Heart Failure in Adult Cancer Survivors of Previous Cardiotoxic Cancer Treatments: Baseline Results of the REDEEM Trial." American Heart Journal 292 (2026): 107277. https://doi.org/10.1016/j.ahj.2025.09.009.

MLA (9th ed.) Citation

J, Wong, et al. "Risk-guided Disease Management to Prevent Heart Failure in Adult Cancer Survivors of Previous Cardiotoxic Cancer Treatments: Baseline Results of the REDEEM Trial." American Heart Journal, vol. 292, 2026, p. 107277, https://doi.org/10.1016/j.ahj.2025.09.009.